受注:045-509-1970 |
技術サポート:[email protected] 平日9:00〜18:00 1営業日以内にご連絡を差し上げます |
製品コード:A2027 Batch: A202701
Daratumumab (anti-CD38) is a recombinant monoclonal antibody to CD38. Daratumumab is an investigational anti-cancer drug which is indicated for the treatment of adult patients with multiple myeloma. MW =145.4 kDa.
CAS No. | 945721-28-8 |
---|---|
Formulation | PBS Buffer, PH 7.4 |
Isotype | Human IgG1 |
Source | Human |
Storage (From the date of receipt) |
Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles |
Shipping | Shipped under low temperature conditions |
Purity | 98.74% |
Protein concentration | 5.09mg/ml |
Endotoxin Level | ≤1 EU/mg |
Developing high-affinity decoy receptors to treat multiple myeloma and diffuse large B cell lymphoma [ J Exp Med, 2022, 219(9)e20220214] | PubMed: 35881112 |
人間や獣医の診断であるか治療的な使用のためにでない。